New Drug: Mosunetuzumab in patients with relapsed or refractory follicular lymphoma
|New Drug: Mosunetuzumab in patients with relapsed or refractory follicular lymphoma|
Lancet Oncol. 2022 Aug; 23(8):1055-1065.
Budde L.E. et al., Safety and efficacy of mosunetuzumab, a bispecific antibody, in patients with relapsed or refractory follicular lymphoma: a single-arm, multicentre, phase 2 study
Reviewed by Elvin CHALABİYEV, MD on Jan 30, 2023
Altai Chemo Planner
Quickly Prepare Accurate Chemotherapy Orders
Altai Chemo Planner employs Altai Protocol Library that includes over 1000 chemotherapy protocols for both Hematology and Oncology. You can find major guidelines' protocols, parenteral, and oral, in the library. Altai Protocol Library is frequently and regularly updated.